Brian J. Brille joined Caris Life Sciences in January 2018 as Vice Chairman & Executive Vice President. Mr. Brille is responsible for several divisions at Caris including the Precision Oncology Alliance (POA), Capital Strategy, Corporate Development, and other activities. He is also a member of the Board of Directors.

Mr. Brille is a senior financial services executive with more than 27 years of experience in investment banking including global leadership positions. In 2003, he was named Investment Dealer’s Digest Banker of the Year.

Prior to joining Caris Life Sciences, Mr. Brille worked in various capacities for Bank of America Merrill Lynch. Most recently, Mr. Brille was based in Hong Kong and served as Chairman & President of Asia Pacific for Bank of America Merrill Lynch, with responsibility for the combined Asia Pacific platform across 12 countries and 4 business lines. Prior to this, he served as Global Head of Corporate and Investment Banking at Bank of America for 5 years. He joined Bank of America in 1999 as Head of Healthcare Investment Banking to build and lead the bank’s healthcare business. He started his career in 1987 in Morgan Stanley’s M&A Department and subsequently founded Morgan Stanley’s Healthcare Services Investment Banking Group.

Mr. Brille holds a JD from Stanford Law School, a Master’s Degree of Public Policy from Harvard’s Kennedy School of Government, and a BS in Accounting from the University of Illinois. He is a Trustee of the Cancer Research Institute (CRI) as well as the International Biochemical Research Alliance (IBRA). He is also on the Board of Overseers of the Museum of Fine Arts (MFA) in Boston.